Article: Tubal Ligation Shown to Reduce Incidence of Ovarian Cancer for BRCA1 Carriers.

Tubal Ligation Shown to Reduce Incidence of Ovarian Cancer for BRCA1 Carriers

ABSTRACT & COMMENTARY

Synopsis: Ovarian cancer occurs frequently in women who carry the BRCA1 and BRCA2 gene mutations. In this multinational, retrospective, case-control study, a prior tubal ligation was shown to provide significant protection against subsequent ovarian cancer development. Thus, tubal ligation is a feasible option to reduce risk of ovarian cancer in women with BRCA1 mutations who have completed childbearing.

Source: Narod SA, et al. Lancet. 2001;357:1467-1470.

The lifetime risk for ovarian cancer in women who carry mutations in the BRCA1 or ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!